A cure for nasopharyngeal cancer is getting closer to reality. Home-grown firm Tessa Therapeutics is conducting what it says is the world’s trial of its kind to treat patients through a specialised form of immunotherapy: virus-specific T-cell therapy. Jose Hong explains the science behind it (The Straits Times, Fri Sep 22, 2017)
Please read more details here. Please click.